Henan Taloph Pharmaceutical Stock Co.,Ltd (SHA:600222)
7.91
+0.61 (8.36%)
Jul 3, 2026, 3:00 PM CST
38.77% (1Y)
| Market Cap | 4.37B +44.1% |
| Revenue (ttm) | 1.78B +1.1% |
| Net Income | 61.07M +98.3% |
| EPS | 0.11 +97.9% |
| Shares Out | 552.92M |
| PE Ratio | 71.85 |
| Forward PE | n/a |
| Dividend | 0.01 (0.18%) |
| Ex-Dividend Date | Jan 9, 2026 |
| Volume | 44,513,751 |
| Open | 7.35 |
| Previous Close | 7.30 |
| Day's Range | 7.30 - 8.03 |
| 52-Week Range | 5.66 - 9.44 |
| Beta | 0.68 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 28, 2026 |